Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,485 | 167 | 72.8% |
| Travel and Lodging | $1,272 | 4 | 26.6% |
| Education | $27.85 | 2 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Covidien LP | $1,651 | 10 | $0 (2017) |
| Gynesonics, Inc. | $604.07 | 2 | $0 (2022) |
| ABBVIE INC. | $569.50 | 48 | $0 (2022) |
| Channel Medsystems, Inc. | $299.55 | 2 | $0 (2024) |
| TherapeuticsMD, Inc. | $185.77 | 13 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $185.35 | 15 | $0 (2024) |
| Agile Therapeutics, Inc. | $140.83 | 7 | $0 (2022) |
| Minerva Surgical, Inc | $138.04 | 4 | $0 (2022) |
| Allergan Inc. | $122.57 | 9 | $0 (2019) |
| Merck Sharp & Dohme LLC | $116.45 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $187.24 | 5 | Channel Medsystems, Inc. ($111.14) |
| 2023 | $194.23 | 17 | Sumitomo Pharma America, Inc. ($142.85) |
| 2022 | $1,251 | 34 | Gynesonics, Inc. ($604.07) |
| 2021 | $583.83 | 43 | AbbVie Inc. ($147.91) |
| 2020 | $192.98 | 13 | AbbVie Inc. ($74.08) |
| 2019 | $291.80 | 19 | AbbVie, Inc. ($80.34) |
| 2018 | $223.35 | 17 | AbbVie, Inc. ($106.43) |
| 2017 | $1,861 | 25 | Covidien LP ($1,651) |
All Payment Transactions
173 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/25/2024 | Channel Medsystems, Inc. | — | Food and Beverage | Cash or cash equivalent | $111.14 | General |
| 03/21/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), GARDASIL 9 | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: VACCINE | ||||||
| 03/09/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: HORMONE THERAPY | ||||||
| 02/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Biological | ||||||
| 01/27/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: HORMONE THERAPY | ||||||
| 12/01/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $7.35 | General |
| Category: HORMONE THERAPY | ||||||
| 11/18/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: HORMONE THERAPY | ||||||
| 11/03/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $7.16 | General |
| Category: HORMONE THERAPY | ||||||
| 10/30/2023 | Hologic Sales and Service, LLC | ACESSA PROVU SYSTEM (Device) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Surgical | ||||||
| 10/20/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $7.12 | General |
| Category: HORMONE THERAPY | ||||||
| 10/06/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $7.00 | General |
| Category: HORMONE THERAPY | ||||||
| 09/15/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: HORMONE THERAPY | ||||||
| 07/28/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $7.69 | General |
| Category: HORMONE THERAPY | ||||||
| 07/25/2023 | Meditrina | — | Food and Beverage | Cash or cash equivalent | $10.85 | General |
| 07/20/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Biological | ||||||
| 06/30/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: HORMONE THERAPY | ||||||
| 06/30/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: HORMONE THERAPY | ||||||
| 06/16/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $6.47 | General |
| Category: HORMONE THERAPY | ||||||
| 05/19/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $6.79 | General |
| Category: HORMONE THERAPY | ||||||
| 04/26/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $7.62 | General |
| Category: HORMONE THERAPY | ||||||
| 03/21/2023 | MAYNE PHARMA COMMERCIAL LLC | NEXTSTELLIS (Drug) | Food and Beverage | In-kind items and services | $5.20 | General |
| Category: CONTRACEPTIVE | ||||||
| 03/10/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: HORMONE THERAPY | ||||||
| 11/11/2022 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: ETONOGESTREL | ||||||
| 10/28/2022 | Channel Medsystems, Inc. | — | Food and Beverage | Cash or cash equivalent | $188.41 | General |
| 09/12/2022 | Minerva Surgical, Inc | — | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Ablation System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 29 | 34 | $4,394 | $1,713 |
| 2022 | 3 | 60 | 77 | $13,318 | $3,617 |
| 2021 | 4 | 86 | 96 | $12,688 | $4,792 |
| 2020 | 4 | 57 | 70 | $10,435 | $3,179 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 21 | $3,360 | $1,231 | 36.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 13 | 13 | $1,034 | $482.30 | 46.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 38 | $6,080 | $1,714 | 28.2% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 14 | 16 | $5,280 | $1,073 | 20.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 23 | 23 | $1,958 | $830.37 | 42.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 38 | $6,025 | $2,300 | 38.2% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 29 | 29 | $2,078 | $1,049 | 50.5% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 11 | 11 | $3,630 | $733.26 | 20.2% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 18 | 18 | $955.00 | $709.92 | 74.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 16 | 25 | $4,000 | $1,260 | 31.5% |
| 76830 | Ultrasound pelvis through vagina | Office | 2020 | 12 | 12 | $3,960 | $886.72 | 22.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 18 | 18 | $900.00 | $665.38 | 73.9% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 11 | 15 | $1,575 | $366.95 | 23.3% |
About Dr. Daniel Dilworth, MD
Dr. Daniel Dilworth, MD is a Obstetrics & Gynecology healthcare provider based in Troy, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336219484.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Dilworth, MD has received a total of $4,785 in payments from pharmaceutical and medical device companies, with $187.24 received in 2024. These payments were reported across 173 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($3,485).
As a Medicare-enrolled provider, Dilworth has provided services to 232 Medicare beneficiaries, totaling 277 services with total Medicare billing of $13,301. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Location Troy, OH
- Active Since 11/08/2006
- Last Updated 07/08/2007
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1336219484
Products in Payments
- V-Loc (Device) $1,584
- SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM (Device) $604.07
- LO LOESTRIN FE (Drug) $332.29
- MYFEMBREE (Drug) $185.35
- ANNOVERA (Drug) $148.37
- Twirla (Drug) $140.83
- NEXPLANON (Drug) $121.15
- Orilissa (Drug) $100.14
- Lupron (Drug) $97.90
- Balcoltra (Drug) $78.65
- LILETTA (Drug) $68.18
- ORILISSA (Drug) $64.68
- Xulane (Drug) $46.51
- SLYND (Drug) $40.78
- Methergine (Drug) $33.66
- Veozah (Drug) $32.29
- Phexxi (Drug) $30.35
- TRINTELLIX (Drug) $29.00
- NUVARING (Drug) $27.13
- Nitronox (Device) $27.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Troy
Dr. David Dulaney, M.d, M.D
Obstetrics & Gynecology — Payments: $33,739
Dr. Faris Ahmad, Md, MD
Obstetrics & Gynecology — Payments: $10,925
Thomas Cacciola, Md, MD
Obstetrics & Gynecology — Payments: $10,027
Jennifer Foley
Obstetrics & Gynecology — Payments: $4,512
Beata Weiermiller, Md, MD
Obstetrics & Gynecology — Payments: $3,428
Adriana Pinkowski, D.o, D.O
Obstetrics & Gynecology — Payments: $2,693